Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis

被引:134
|
作者
Eder, Lihi [1 ]
Thavaneswaran, Arane [1 ]
Chandran, Vinod [1 ]
Cook, Richard J. [2 ]
Gladman, Dafna D. [1 ]
机构
[1] Univ Toronto, Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Psoriat Arthrit Clin, Toronto, ON M5T 2S8, Canada
[2] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada
基金
加拿大健康研究院;
关键词
BODY-MASS INDEX; MARGINAL STRUCTURAL MODELS; WEIGHT-LOSS; RISK; SEVERITY; POPULATION; ADIPOKINES; PSA;
D O I
10.1136/annrheumdis-2013-204448
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To assess whether overweight and obese patients with psoriatic arthritis (PsA) are less likely to achieve sustained minimal disease activity (MDA) state compared to patients with normal weight. Methods A cohort of patients was assessed at the University of Toronto PsA clinic at 6-12-month intervals according to a standard protocol from 2003 to 2012. Patients were categorised into the following groups according to their body mass index (BMI): normal (< 25), overweight (25-30), and obese (> 30). Sustained MDA was defined as achieving low disease activity state in five or more of the following domains for at least 1 year: skin, enthesitis, tender and swollen joint counts, pain, patient global assessment and function. Proportional odds discrete time to event analysis was used to investigate the association between BMI category and the achievement of sustained MDA. Results Of the 557 patients included in the study, 36.2% were classified as overweight and 35.4% were obese. Overall, 66.1% of the patients achieved sustained MDA during the follow-up period. A dose-response association was found between obesity and the probability of achieving sustained MDA in the multivariate regression analysis. Patients in the higher BMI categories were less likely to achieve sustained MDA compared those in the lowest BMI category (overweight: OR 0.66 p= 0.003; obese: OR 0.53 p< 0.0001) after adjusting for potential confounding variables. Conclusions Overweight and obese patients with PsA are less likely to achieve sustained MDA compared to those of normal weight.
引用
收藏
页码:813 / 817
页数:5
相关论文
共 50 条
  • [21] Frequency, Predictors, and Prognosis of Sustained Minimal Disease Activity in an Observational Psoriatic Arthritis Cohort
    Coates, Laura C.
    Cook, Richard
    Lee, Ker-Ai
    Chandran, Vinod
    Gladman, Dafna D.
    ARTHRITIS CARE & RESEARCH, 2010, 62 (07) : 970 - 976
  • [22] Minimal Disease Activity among Psoriatic Arthritis Patients in Canada: Evaluation of Modified Minimal Disease Activity upon Elimination of Each Component
    Haraoui, Boulos
    Rahman, Proton
    Bessette, Louis
    Baer, Philip
    Kapur, Suneil
    Avina-Zubieta, Antonio
    Arendse, Regan
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Lehman, Allen
    Maslova, Karina
    Nantel, Francois
    Osborne, Brendan
    Tkaczyk, Cathy
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1184 - 1184
  • [23] Minimal Disease Activity Among Psoriatic Arthritis Patients in Canada: Evaluation of Modified Minimal Disease Activity upon Elimination of Each Component
    Haraoui, Boulos
    Rahman, Proton
    Bessette, Louis
    Baer, Philip
    Kapur, Suneil
    Avina-Zubieta, J. Antonio
    Arendse, Regan
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Maslova, Karina
    Lehman, Allen J.
    Nantel, Francois
    Osborne, Brendan
    Tkaczyk, Cathy
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [24] Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: the UPSTREAM (Ultrasound in PSoriatic arthritis TREAtMent) prospective observational study protocol
    Canzoni, Marco
    Piga, Matteo
    Zabotti, Alen
    Scire, Carlo Alberto
    Carrara, Greta
    Olivieri, Ignazio
    Iagnocco, Annamaria
    BMJ OPEN, 2018, 8 (07):
  • [25] Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
    Ennio Lubrano
    Fabio Massimo Perrotta
    Silvia Scriffignano
    Laura C. Coates
    Philip Helliwell
    Rheumatology and Therapy, 2019, 6 : 521 - 528
  • [26] Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
    Lubrano, Ennio
    Perrotta, Fabio Massimo
    Scriffignano, Silvia
    Coates, Laura C.
    Helliwell, Philip
    RHEUMATOLOGY AND THERAPY, 2019, 6 (04) : 521 - 528
  • [27] Impact of Achieving Minimal Disease Activity on Patient-Reported Outcome Measures and Disease Activity Among Patients with Psoriatic Arthritis Treated with Biologic and Targeted Synthetic DMARDs
    Ogdie, Alexis
    McLean, Robert
    Marchese, Maya
    Blachley, Taylor
    Anatale-Tardiff, Laura
    Saffore, Christopher
    Douglas, Kevin
    Quach, Danny
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2798 - 2801
  • [28] PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH APREMILAST
    Mease, Philip J.
    Behrens, Frank
    Gladman, Dafna D.
    Kavanaugh, Arthur
    Brunori, Michele
    Teng, Lichen
    Guerette, Benoit
    Queiro, Ruben
    Ogdie, Alexis
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 916 - 917
  • [29] Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity
    Yilmazer, Baris
    Sahin, Tayfun
    Unlu, Berrin Oztas
    Kir, Hale Maral
    Cefle, Ayse
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (08) : 1385 - 1392
  • [30] Residual inflammation in psoriatic arthritis patients in stable minimal disease activity
    Macchioni, Pierluigi
    Marchesoni, Antonio
    Ciancio, Giovanni
    Sandri, Gilda
    Zabotti, Alen
    Vukatana, Gentiana
    Montaguti, Luca
    Focherini, Mariacristina
    Govoni, Marcello
    Spinella, Amelia
    Malavolta, Nazzarena
    Zuliani, Francesca
    Bruschi, Marco
    Mascella, Fabio
    Salvarani, Carlo
    FRONTIERS IN MEDICINE, 2022, 9